February - 2014
| Previous Next | Showing Journal 8 of 11 |
The Beta Agonist Lung Injury Trial (BALTI) Prevention: A Randomized Controlled TrialGavin D Perkins, Simon Gate, Daniel Park, et al on behalf of the BALTI-Prevention Collaborators AJRCCM, 2014, online first This page is only available to Crit-IQ subscribers. To view the rest of this review and gain access to our vast array of critical care teaching tools including podcasts, vodcasts, modules, exam preparation tools, teaching aids and much more, login here, or Become a Member to register |
February |
Previous Comments
No Comments yet.
Comment
The potential of benefit of inhaled or IV beta-agonists in ALI/ARDS is controversial, with the recent BALTI-2 and ALTA studies showing no benefit or harm. This prospective RCT performed in the UK randomised 362 patients undergoing oesophagectomy to beta-agonists (salmeterol 100 mcg bd) vs...